NEULANDLAB•NSE
Need professional-grade analysis? Visit stockanalysis.com
₹15,295.00
+1.97%
End of day
Market Cap
$192.45B
P/E Ratio
107.66
Employees
1,794
Dividend Yield
N/A
Price Chart
Risk-Adjusted Performance
Neuland Laboratories Limited (NEULANDLAB) Price Performance
Neuland Laboratories Limited (NEULANDLAB) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR15295.00, up 1.97% from the previous close.
Over the past year, NEULANDLAB has traded between a low of INR11995.00 and a high of INR18113.00. The stock has gained 19.2% over this period. It is currently 15.6% below its 52-week high.
Neuland Laboratories Limited has a market capitalization of $192.45B, with a price-to-earnings ratio of 107.66.
About Neuland Laboratories Limited
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Company Info
- Sector
- Healthcare
- Exchange
- NSE
- Currency
- INR
- Country
- India
Financial Metrics
- Revenue (TTM)
- $6.06B
- EBITDA
- $534.17M
- Profit Margin
- 2.29%
- EPS (TTM)
- 139.33
- Book Value
- 1262.78
Technical Indicators
- 52 Week High
- ₹19,747.00
- 52 Week Low
- ₹11,521.00
- 50 Day MA
- ₹13,010.36
- 200 Day MA
- ₹14,503.63
- Beta
- -0.32
Valuation
- Trailing P/E
- 107.66
- Forward P/E
- 18.38
- Price/Sales
- 31.77
- Price/Book
- 11.86
- Enterprise Value
- $193.15B